NCT07797608

Brief Summary

This randomized controlled trial aims to evaluate the effect of progressive muscle relaxation exercises on anxiety levels among parents who are the primary caregivers of children diagnosed with cancer and receiving inpatient treatment. A total of 112 parents will be randomly assigned to either the intervention or control group. Parents in the intervention group will participate in researcher-led progressive muscle relaxation sessions. Anxiety will be assessed using the State Anxiety Inventory (STAI-I). The study will be conducted at the Pediatric Hematology-Oncology Clinic of Akdeniz University Hospital in Antalya, Türkiye.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
112

participants targeted

Target at P50-P75 for not_applicable

Timeline
9mo left

Started Aug 2026

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress15%
Aug 2026Jul 2027

First Submitted

Initial submission to the registry

August 10, 2026

Completed
5 days until next milestone

Study Start

First participant enrolled

August 15, 2026

Completed
17 days until next milestone

First Posted

Study publicly available on registry

September 1, 2026

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 20, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 20, 2027

Last Updated

September 9, 2026

Status Verified

September 1, 2026

Enrollment Period

11 months

First QC Date

August 10, 2026

Last Update Submit

September 7, 2026

Conditions

Keywords

ParentAnxietyCancerProgressive Muscle RelaxationNursing

Outcome Measures

Primary Outcomes (1)

  • Change in State Anxiety

    State anxiety will be measured using the State Anxiety subscale of the State-Trait Anxiety Inventory (STAI-S). The subscale contains 20 items and yields a total score ranging from 20 to 80. Higher scores indicate higher state anxiety.

    2 weeks

Study Arms (2)

Progressive Muscle Relaxation

EXPERIMENTAL

Participants will receive two individual progressive muscle relaxation sessions in a private clinical education room over two weeks. Each session will last approximately 15 minutes and will be conducted once weekly.

Behavioral: Progressive Muscle Relaxation

Control

NO INTERVENTION

Participants in the control group will receive routine care provided by the clinic and will not participate in progressive muscle relaxation sessions during the study period.

Interventions

Participants will receive routine clinical care and will not participate in progressive muscle relaxation sessions during the study period.

Progressive Muscle Relaxation

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Being the parent and primary caregiver of a child diagnosed with cancer
  • The child having been diagnosed with cancer within the previous 12 months
  • The child currently receiving inpatient treatment in the study clinic
  • Being able to communicate without hearing or speech-related barriers
  • Being able to understand and answer the study questions
  • Providing written informed consent

You may not qualify if:

  • Withdrawing consent at any time

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Anxiety DisordersNeoplasms

Interventions

Autogenic Training

Condition Hierarchy (Ancestors)

Mental Disorders

Intervention Hierarchy (Ancestors)

HypnosisMind-Body TherapiesComplementary TherapiesTherapeuticsPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Duygu Altuntaş, PhD

    Akdeniz University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer, PhD

Study Record Dates

First Submitted

August 10, 2026

First Posted

September 1, 2026

Study Start

August 15, 2026

Primary Completion (Estimated)

July 20, 2027

Study Completion (Estimated)

July 20, 2027

Last Updated

September 9, 2026

Record last verified: 2026-09

Data Sharing

IPD Sharing
Will not share